PAX5 and leukemia: However, on the other hand, genomic analysis of Pax5+/− mice subjected to mutagenesis identified secondary genetic alterations that recapitulate those observed in human leukemia, as is the case of secondary alterations of Pax5 or recurrent mutations in genes such as Jak1, Jak3, Ptpn11, and Nras [31].